Striking effect of hydroxamic acid substitution on the phosphodiesterase type 4 (PDE4) and TNF alpha inhibitory activity of two series of rolipram analogues: implications for a new active site model of PDE4.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples